Gregory T Lucier bought $110k of XRAY
director at DENTSPLY SIRONA Inc.. 6,000 shares at an average of $18.35, traded Nov 15, 2024, filed Nov 18, 2024.
Score components
- +15RoleDirector
- +10Trade size$110k at market
- +6Relative to holdingsHoldings up 40%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.2%, 3m +0.1%, 6m -8.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-24-027492, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | POpen-market purchase Common Stockindirect: by Gregory Lucier IRA | +1,000 | $18.28 | $18k | 16,000 | Nov 18, 2024 |
| Nov 18, 2024 | POpen-market purchase Common Stock | +5,000 | $18.37 | $92k | 71,730 | Nov 18, 2024 |
Related signals
Other insiders at DENTSPLY SIRONA Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | XRAYbuy DENTSPLY SIRONA Inc. | Gregory T Lucier director | $250k 15,142 shares | +23% | |
| 45Moderate | DENTSPLY SIRONA Inc. | Simon D Campion President, CEO & Member of BOD | $200k 11,306 shares | +4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.